BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38369810)

  • 1. Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates.
    Fida N; Eagar TN; Yun AN; Rogers AW; Nguyen DT; Graviss EA; Ishaq F; DiPaola NR; Kim J; Janardhana G; Kassi M; Yousefzai R; Suarez EE; Bhimaraj A; Krisl JC; Guha A
    Clin Transplant; 2024 Feb; 38(2):e15249. PubMed ID: 38369810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
    Ezekian B; Schroder PM; Mulvihill MS; Barbas A; Collins B; Freischlag K; Yoon J; Yi JS; Smith F; Olaso D; Saccoccio FM; Permar S; Farris AB; Kwun J; Knechtle SJ
    J Am Soc Nephrol; 2019 Dec; 30(12):2399-2411. PubMed ID: 31658991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
    Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
    Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition.
    Alishetti S; Farr M; Jennings D; Serban G; Uriel N; Sayer G; Vasilescu R; Restaino S; Chong AS; Habal MV
    Am J Transplant; 2020 Dec; 20(12):3620-3630. PubMed ID: 32506824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
    Sriwattanakomen R; Xu Q; Demehin M; Shullo MA; Mangiola M; Hickey GW; Sciortino CM; Horn ET; Keebler ME; Zeevi A
    J Heart Lung Transplant; 2021 Jul; 40(7):595-603. PubMed ID: 33785250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody desensitization therapy in highly sensitized lung transplant candidates.
    Snyder LD; Gray AL; Reynolds JM; Arepally GM; Bedoya A; Hartwig MG; Davis RD; Lopes KE; Wegner WE; Chen DF; Palmer SM
    Am J Transplant; 2014 Apr; 14(4):849-56. PubMed ID: 24666831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab.
    Lobashevsky AL; Higgins NG; Rosner KM; Mujtaba MA; Goggins WC; Taber TE
    Transplantation; 2013 Jul; 96(2):182-90. PubMed ID: 23778648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA desensitization with bortezomib in a highly sensitized pediatric patient.
    May LJ; Yeh J; Maeda K; Tyan DB; Chen S; Kaufman BD; Bernstein D; Rosenthal DN; Hollander SA
    Pediatr Transplant; 2014 Dec; 18(8):E280-2. PubMed ID: 25174602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
    Patel J; Everly M; Chang D; Kittleson M; Reed E; Kobashigawa J
    J Heart Lung Transplant; 2011 Dec; 30(12):1320-6. PubMed ID: 21968130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidates.
    Nair V; Sawinski D; Akalin E; Friedlander R; Ebcioglu Z; Sehgal V; Dinavahi R; Khaim R; Ames S; Lerner S; Murphy B; Bromberg JS; Heeger PS; Schröppel B
    Clin Transplant; 2012; 26(3):E261-8. PubMed ID: 22686949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers.
    Joher N; Matignon M; Grimbert P
    Front Immunol; 2021; 12():688301. PubMed ID: 34093594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bortezomib desensitization among heart transplant candidates.
    Brinkley DM; Mangione M; Fossey SC; Harrison KM; Zalawadiya S; Rali AS; Siddiqi HK; Lindenfeld J; Schlendorf KH
    Clin Transplant; 2023 Apr; 37(4):e14907. PubMed ID: 36661196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization for sensitized patients awaiting heart transplant.
    Byku M; Chang PP
    Curr Opin Organ Transplant; 2019 Jun; 24(3):233-238. PubMed ID: 31090629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients.
    Burghuber CK; Manook M; Ezekian B; Gibby AC; Leopardi FV; Song M; Jenks J; Saccoccio F; Permar S; Farris AB; Iwakoshi NN; Kwun J; Knechtle SJ
    Am J Transplant; 2019 Mar; 19(3):724-736. PubMed ID: 30102844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum dilutions as a predictive biomarker for peri-operative desensitization: An exploratory approach to transplanting sensitized heart candidates.
    Timofeeva OA; Alvarez R; Pelberg J; Yoon E; Alsammak M; Geier SS; Ruggia-Check C; Hassler J; Hoosain J; Brisco MA; Afari-Armah N; Rakita V; Brann S; Keshavamurthy S; Gomez-Abraham J; Minakata K; Toyoda Y; Hamad E
    Transpl Immunol; 2020 Jun; 60():101274. PubMed ID: 32142756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization in heart transplant recipients: Who, when, and how.
    Shah KS; Patel J
    Clin Transplant; 2019 Aug; 33(8):e13639. PubMed ID: 31206862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, iterative, adaptive trial of carfilzomib-based desensitization.
    Tremblay S; Driscoll JJ; Rike-Shields A; Hildeman DA; Alloway RR; Girnita AL; Brailey PA; Woodle ES
    Am J Transplant; 2020 Feb; 20(2):411-421. PubMed ID: 31550069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of urgent desensitization in sensitized heart transplant recipients.
    Fu HY; Wang YC; Tsao CI; Yu SH; Chen YS; Chou HW; Chi NH; Wang CH; Hsu RB; Huang SC; Yu HY; Chou NK
    J Formos Med Assoc; 2022 May; 121(5):969-977. PubMed ID: 34340891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of desensitization protocol with and without rituximab in sensitized kidney transplant recipients.
    Green H; Nesher E; Aizner S; Israeli M; Klein T; Zakai H; Rahamimov R; Rozen-Zvi B; Mor E
    Clin Transplant; 2019 Jun; 33(6):e13562. PubMed ID: 30941818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Role for Desensitization in Intestinal Transplantation?
    Santeusanio AD; Moon J; Nair V; Iyer KR
    Prog Transplant; 2019 Sep; 29(3):275-278. PubMed ID: 31170898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.